7 terminated. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Terminated 7 |
Follow Interstitial Cystitis: new trials by email Literature Review of Interstitial Cystitis trials Research Report on Interstitial Cystitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome IW-3300 rectal foam, Placebo - Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Terminated | Ironwood Pharmaceuticals, Inc. | 98 | 2023-03-28 | 2025-02-28 |
| Low-dose Naltrexone for Bladder Pain Syndrome Naltrexone, Placebo - Bladder Pain Syndrome, Interstitial Cystitis | Phase 2 | Terminated | Stanford University | 29 | 2020-10-08 | 2026-07-10 |
| Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome URG101, Placebo, Lidocaine - Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Terminated | Urigen | 91 | 2015-09-01 | 2026-02-03 |
| Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis LiRIS 400 mg, LiRIS Placebo - Interstitial Cystitis | Phase 2 | Terminated | Allergan | 31 | 2013-03-01 | 2016-01-26 |
| Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis Lidocaine Releasing Intravesical System - LiRIS®, LiRIS Placebo, Sham Cystoscopy Procedure - Interstitial Cystitis | Phase 2 | Terminated | Allergan | 104 | 2011-11-01 | 2015-09-21 |
| Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis URG101, Placebo - Painful Bladder Syndrome, Interstitial Cystitis | Phase 2 | Terminated | Urigen | 28 | 2007-08-28 | 2024-08-23 |
| Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC) dimethyl sulfoxide, IC Cocktail - Interstitial Cystitis, Bladder Diseases | Phase 2 | Terminated | Nova Scotia Health Authority | 10 | 2006-04-01 | 2009-05-11 |
Cystitis, Interstitial (7) · Pain (1) · Urinary Bladder Diseases (1)
Cystitis (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Male Urogenital Diseases (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Urinary Bladder Diseases (6) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Dimethyl Sulfoxide (1) · Exercise (1) · Heparin (1) · Lidocaine (1) · Naltrexone (1)
Allergan (2) · Urigen (2) · Ironwood Pharmaceuticals, Inc. (1) · Nova Scotia Health Authority (1) · Stanford University (1)
United States (6) · Canada (3)
Curtis Nickel, MD (2) · C. Lowell Parsons, MD (1) · Craig V Comiter, MD (1) · Jeff Proctor, M.D. (1) · Jennifer M Hah, MD, MS (1) · Jerzy Gajewski, MD, FRCSC (1) · Phil Hanno, MD (1)